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Human cytomegalovirus (HCMV) encodes at least 14 microRNAs (miRNAs) that act posttranscriptionally
to repress gene expression. Although several HCMV miRNA targets of both cellular and viral origin have been
identified, our knowledge of their function remains limited. HCMV miRNA targets, as well as phenotypes
associated with HCMV miRNA mutants, have been difficult to identify since the downregulation of targets by
a single miRNA is often less than 2-fold. Several factors can contribute to the strength of repression, including
the mechanism of translational inhibition, the degree of complementarity between the miRNA and target
mRNA, the number of binding sites for one miRNA, and cooperativity or antagonism between miRNAs. To
determine the effect of multiple miRNAs on one gene, we examined the repression of a viral gene, US7. Here
we demonstrate that the HCMV-encoded miRNAs miR-US5-1 and miR-US5-2 function in a highly synergistic
manner to regulate US7, even at very low miRNA concentrations. Regulation of US7 involves three functional
miRNA binding sites: two that are completely complementary to the 3 untranslated region (3UTR) and one
that is imperfectly matched. Surprisingly, we observed equal contributions to inhibition from both complete
and partially complementary sites, and repression was not completely abrogated until all three sites were
mutated simultaneously. We also observed that the miRNA binding sites did not follow the spacing constraints
for corepressive miRNAs observed in earlier reports. These results underscore the importance of evaluating the
contribution of multiple miRNAs on gene regulation and shed new insight into miRNA:mRNA interactions.
MicroRNAs (miRNAs) are small noncoding RNA mole-
cules of 19 to 24 nucleotides (nt) in length. They play an
important role in a wide variety of biological processes includ-
ing development, differentiation, hematopoiesis, angiogenesis,
and cancer (reviewed in reference 1). Their biological signifi-
cance can be attributed to the ability of each miRNA to target
at least 100 genes (6, 10, 21). Although many studies have
sought to define the rules that govern miRNA:mRNA inter-
actions, a lack of complete understanding of these interactions
impedes miRNA target identification (22, 34).
miRNAs direct RNA-induced silencing complexes (RISC)
to target genes by binding to sites of sequence complementa-
rity within the mRNA. Most miRNA binding sites are located
within the 3 untranslated regions (3UTRs) of mRNAs; how-
ever, sites within 5UTRs or coding regions have also been
identified (14, 23, 25). The earliest studies indicate that most
mammalian miRNAs are not completely complementary to the
mRNA, yet a stretch of 6 to 8 nucleotides in the 5 end of the
miRNA that is complementary to the mRNA primarily medi-
ates interaction (termed the seed sequence) (4, 6, 15, 21).
Complete complementarity between a miRNA and an mRNA
directs site-specific endonucleolytic cleavage of the mRNA,
resulting in decreased abundance of the message (reviewed in
references 3 and 9). Incomplete complementarity, as seen in
most mammalian cells, results in translational repression due
to translation inhibition and mRNA decay. In these cases, a
single miRNA:mRNA interaction may have only a nominal
effect (4-fold) on gene expression (2, 31). However, stronger
repression is observed when a gene contains multiple binding
sites for the same miRNA (16, 30). Furthermore, multiple
miRNAs can act concomitantly on the same 3UTR to affect
gene expression. Several recent reports have demonstrated
cooperative and antagonistic interactions between miRNAs
(11, 16, 17, 20, 24, 26, 30, 35, 37, 38). Cooperativity can lead to
enhanced repression when miRNA binding sites are ideally
spaced (16 to 35 nt apart) within the 3UTR (16, 30).
The betaherpesvirus human cytomegalovirus (HCMV) is
ubiquitous among the human population and, while normally
benign, is a significant pathogen in immunosuppressed individ-
uals. HCMV is also the leading infectious cause of congenital
birth defects. HCMV encodes at least 14 miRNAs expressed
from 11 unique RNA structures (12, 27, 36). Our lab and
others have identified both viral and cellular targets of HCMV-
encoded miRNAs. miR-UL112-1 regulates multiple viral genes
including the major immediate early gene product IE72, a
major trans-activator of viral gene transcription (13). Addi-
tional studies by authors Stern-Ginossar et al. (32) have dem-
onstrated that miR-UL112-1 targets the major histocompati-
bility complex chain B, a cellular gene involved in host immune
responses to viral infection. miR-UL112-1 acts in concert with
cellular miRNAs to enhance repression (24). We have recently
shown that miR-US25-1 targets many cellular genes associated
with cell cycle control, including cyclin E2, BRCC3, EID1,
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MAPRE2, and CD147, through the unusual mechanism of
binding to sites within the 5UTR of mRNA transcripts (14).
HCMV-encoded miRNAs are expressed coordinately in in-
fected human fibroblasts. We hypothesized that viral miRNAs
may function together to regulate both viral and cellular gene
expression. In the current study we found that HCMV tightly
regulates the expression of one of its own genes, US7, by using
two different miRNAs, miR-US5-1 and miR-US5-2. Regula-
tion by miR-US5-1 and miR-US5-2 is highly synergistic, dem-
onstrating cooperativity among the miRNAs. Both miR-US5-1
and miR-US5-2 are encoded on the strand opposing the US7
3UTR and therefore each binds to the 3UTR with complete
complementarity. Additionally, we found a second functional
miR-US5-2 binding site in the US7 3UTR. We demonstrate
that binding to the miR-US5-2 site that is completely comple-
mentary induces degradation of the mRNA, but binding to the
second site does not. To our knowledge this is the first report
of a gene that is regulated by two distinct miRNA-directed
mechanisms. Surprisingly both miR-US5-2 sites contribute
equally to regulation of the 3UTR, despite the differences in
mRNA abundance. We also observed that the distances be-
tween each set of miRNA binding sites were greater than 79
bases. This is far greater than the ideal distances seen between
cooperative binding sites in previous papers (16, 30). These
new findings highlight the value of using viruses to study bio-
logical processes.
MATERIALS AND METHODS
Reagents. Double-stranded miRNA mimics were designed using published
miRNA sequences (www.mirbase.org). The guide strand sequence matched the
published sequence, while the passenger strand sequence contained a mismatch
in the 3 end of the strand. Sequences were as follows: for miR-US5-1, guide
UGACAAGCCUGACGAGAGCGU and passenger UCGCUCUCGUCAGGC
UUGUUAUG; for miR-US5-2, guide UUAUGAUAGGUGUGACGAUG
UCUU and passenger GACAUCGUCACACCUAUCAUCAGA. Annealed
mimics were purchased from IDT. Negative control small interfering RNA
(siRNA) was purchased from Ambion.
Cloning and site-directed mutagenesis. The 3UTR of US7 was PCR amplified
from total viral cDNA by using a US7-specific forward primer (GCGCCCTAGGA
TAAACTGTTAGGTTCG) and an oligo(dT) reverse primer (TCAGCACTGTC
GAGCTCCTTAAGCTTTTTTTTTTTTTTTTTT) and cloned downstream of the
firefly luciferase (Fluc) gene in the pMIR kanamycin (Kan) luciferase single-re-
porter construct (13). A PCR-based site-directed mutagenesis protocol was used to
introduce mutations into potential miRNA binding sites (QuikChange site-directed
mutagenesis; Stratagene). The following mutagenesis primers were used: for miR-
US5-1, forward (GATGAACGCTCTCGTCAGGACTAGTATGGTCTGTAAAA
GCTGCATG) and reverse (CATGCAGCTTTTACAGACCATACTAGTCCTGA
CGAGAGCGTTCATC); miR-US5-2 Mut 1 primer, forward (AAAGACATCGT
CACACCGAATTCAGAATGCAACGCTTTCA) and reverse (TGAAAGCGTT
GCATTCTGAATTCGGTGTGACGATGTCTTT); and miR-US5-2 Mut 2
primer, forward (ACTCACGTCACACGTTACCTCGAGCAACGTAGGGCGG
TATTT) and reverse (AAATACCGCCCTACGTTGCTCGAGGTAACGTGTG
ACGTGAGT). The wild-type (WT) US7 3UTR and the US7 3UTRs containing
the miR-US-5-2 mutations, or the miR-US5-2 mutations and the miR-US5-1 mu-
tation, were then PCR amplified from the pMIR Kan constructs (forward [GCGG
AGCTCTAAACTGTTAGGTTCGTTATAAGC] and reverse [GCGGCGGCCG
CGAGACGATAAAACAGCATCAGG]) and subcloned downstream of the
Renilla luciferase (Rluc) gene in the psiCHECK-2 dual reporter construct (Pro-
mega). The US7 3UTR containing the single miR-US5-1 mutation was subcloned
directly from the pMIR Kan construct into the psiCHECK-2 plasmid by using
existing restriction sites.
Cells and viruses. HEK293T and primary human fibroblasts were maintained
in DMEM supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin-glutamine. The AD169 strain of HCMV was grown and titered in
human fibroblasts by using standard techniques. The entire 70-nt sequence
coding for miR-US5-1 or miR-US5-2 was deleted from the AD169 bacterial
artificial chromosome (BAC) clone by using BAC technology, as previously
described (29). For the double mutant, the entire region encompassing both
miRNAs was deleted. Briefly, a PCR-amplified cassette containing FLP recom-
bination target (FRT)-flanked kanamycin was recombined into the BAC replac-
ing the indicated sequences. miR-US5-1 deletion primers were as follows: for-
ward, GTTGTATGATGTAACGTGTGACGTGAGTCTGATCCAACACTGT
AAAACGACGGCCAG; reverse, CAAATATATGGAGTTTGTGTAATGCG
TACTTCATGCCCCGATCAGGAAACAGCTATGAC. miR-US5-2 deletion
primers were as follows: forward, ACAAACTCCATATATTTGTTACGATAG
AATACGGAACGGAGTAAAACGACGGCCAG; reverse, GATGAATGTC
ATCATCACGCAAAGCAGCCGTGGGAATGGTCAGGAAACAGCTAT
GAC. miR-US5-1 and miR-US5-2 deletion primers were as follows: forward,
ACAAACTCCATATATTTGTTACGATAGAATACGGAACGGAGTAAAA
CGACGGCCAG; reverse, CAAATATATGGAGTTTGTGTAATGCGTACTT
CATGCCCCGATCAGGAAACAGCTATGAC. The kanamycin cassette was
then removed by recombining the FRT sites through induction of a FLIP re-
combinase. The resulting BACs were isolated and electroporated into human
fibroblasts to generate infectious virus.
Immunoprecipitations. Infected primary human fibroblasts (multiplicity of
infection [MOI]  3) were incubated with cysteine- and methionine-free media
for 60 min at the indicated times postinfection. The cells were then labeled with
125 Ci of [35S]methionine (EasyTag ExpreSS; Perkin Elmer) for 1 h prior to
cell harvest. Immunoprecipitations were performed using an antibody specific for
US7 (18) and glycoprotein H (gH) (5).
Luciferase assay. Double-stranded miRNA mimics were cotransfected into
HEK293T cells with either single-reporter constructs and a control construct that
expressed Rluc (pRL; Promega) or the dual reporter constructs by using Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Rluc
and Fluc expression was measured 18 h posttransfection using the dual-luciferase
reporter assay (Promega). Results were normalized to the corresponding control
reporter construct (Rluc in the case of single-reporter constructs and Fluc for the
psiCHECK-2 system) and are reported as percent expression relative to cells
transfected with a negative control miRNA.
For the isobologram analysis, HEK293T cells were seeded at 1.0  104 cells/
well in 96-well plates. Cells were cotransfected with the 3UTR psiCHECK-2
reporter constructs and serial dilutions of miR-US5-1 and miR-US5-2 mimics (0,
6.7, 13.3, 26.7, 53.3, 106.7, 213.3, 426.7 pM) alone or in combination using
Lipofectamine 2000 (Invitrogen). Combinations of miR-US5-1/miR-US5-2 doses
leading to 50% inhibition of Rluc activity (IC50) were determined from titration
curves corresponding to one concentration of miR-US5-1 with increasing con-
centrations of miR-US5-2 and vice versa. Isobolograms were drawn by plotting
each of these dose pairs on a Cartesian diagram (33).
Western blot analysis. Cell extracts were run on an 8–12% SDS-PAGE gel,
transferred to Immobilon-P transfer membranes (Milipore Corp.), and visual-
ized with antibodies specific for luciferase (Sigma), Argonaute 2 (14), and
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Abcam).
RT and real-time PCR. Cells were lysed directly in TRIzol, and total RNA was
extracted following the manufacturer’s recommendations (Invitrogen). For each
sample, 250 ng of total RNA was treated with DNase I before being reverse
transcribed using hexanucleotide primers and Multiscribe reverse transcriptase
(ABI). Sybr green real-time PCR was performed in duplicate using 2 l of each
reverse transcription (RT) reaction and primer pairs specific for US7 (forward
[ATCTCACACCGTCAGCTGCGTAAT], reverse [AGGCACGTTATACAAG
CCACTGGT]), GAPDH (forward [TCGACAGTCAGCCGCATCTTCTTT],
reverse [ACCAAATCCGTTGACTCCGACCTT]), Rluc (forward [ATTCAAG
GAGAAGGGCGAGGTT], reverse [AGGCGTTGTAGTTGCGGACAAT]),
and Fluc (forward [TGCAGTTCTTCATGCCAGTGCT], reverse [TAGGCTG
AGAAATGCCCATGCT]). Relative quantities between samples were deter-
mined by the CT method using GAPDH and Fluc as references for US7 and
Rluc, respectively.
RESULTS
HCMV US7 is cotargeted by miR-US5-1 and miR-US5-2.
miR-US5-1 and miR-US5-2 are two HCMV-encoded miRNAs
that lie within close proximity to one another in the viral
genome. They are encoded on the opposing strand of an
HCMV gene of unknown function called US7 (Fig. 1A). Both
miRNAs are completely complementary to the US7 3UTR
and therefore are predicted to target US7 to RISC.
To determine whether miR-US5-1 and miR-US5-2 regulate
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the US7 transcript, cells were cotransfected with reporter con-
structs encoding the US7 3UTR and double-stranded RNA
mimics of miR-US5-1 and miR-US5-2. Luciferase assays re-
vealed that each miRNA alone decreased reporter activity by
approximately 50% (Fig. 1B). When miR-US5-1 and miR-
US5-2 were combined, reporter activity was decreased by ap-
proximately 75%. In contrast, miR-US5-1 and miR-US5-2 had
no effect on a control 3UTR, when transfected either alone or
in combination with one another. Comparable results were
seen when Western blot analysis was used to analyze total
luciferase protein expression (Fig. 1C).
These results show that miR-US5-1 and miR-US5-2 each
target the US7 3UTR and that targeting by two miRNAs has
a more robust effect than does targeting by either miRNA
alone.
miR-US5-1 and miR-US5-2 act synergistically to regulate
US7. To determine whether miR-US5-1 and miR-US5-2 act
additively or synergistically to reduce expression of US7, we
used an isobologram analysis commonly utilized for drug in-
teractions. An isobologram is defined as a graph of equally
effective dose pairs (isoboles) for a single effect level. Specifi-
cally, a particular effect level is selected, such as 50% of the
maximum, and doses of drug A and drug B (each alone) that
give this effect are plotted as axial points in a Cartesian plot
(33). The straight line connecting A and B represents the dose
pairs that will produce this effect in a simply additive combi-
nation. Points located below the additivity line denote lesser
quantity of each drug necessary to reach the same effect (syn-
ergistic effect). Conversely, points above the line denote an-
tagonism between the 2 drugs.
Luciferase reporter constructs were transfected with increas-
ing concentrations of one of the miRNA mimics while holding
the second miRNA constant, and vice versa. miRNA dose
pairs that caused 50% inhibition of luciferase activity (IC50)
were determined from titration curves and plotted on a graph
(Fig. 2A). All data points were below the additivity line, indi-
cating synergy between miR-US5-1 and miR-US5-2. To rule
out the possibility that miRNA combinations generate isobo-
lograms with nonspecific synergistic effect, we also performed
an additivity control isobologram by combining miR-US5-2
with itself (Fig. 2B). As expected, the pairs of miR-US5-2 doses
scattered along the additivity line. These data demonstrate that
miR-US5-1 and miR-US5-2 have a synergistic effect on the
HCMV US7 3UTR.
miR-US5-1 interacts with the US7 3UTR at one site. To
determine whether miR-US5-1 regulates US7 by binding to the
identified site present within the 3UTR, six bases in the miR-
US5-1 seed sequence were mutated using site-directed mu-
tagenesis. Mutation of the miR-US5-1 target site completely
restored luciferase activity in the presence of miR-US5-1 (Fig.
3), suggesting that miR-US5-1 regulates US7 by binding to the
one target site within the 3UTR. As expected, mutation of the
miR-US5-1 target site had no effect on miR-US5-2 regulation
of the US7 3UTR. This result demonstrates that miR-US5-1
interacts with the US7 3UTR at one site.
miR-US5-2 interacts with the US7 3UTR at two sites. Sim-
ilarly, we used site-directed mutagenesis to determine whether
miR-US5-2 interacts with the US7 3UTR by binding to the
identified site. Surprisingly, we observed only partial restora-
tion of expression when the miR-US5-2 binding site was mu-
tated (Fig. 4A, Mut 1). Luciferase expression was only partially
restored to 50% of the levels seen after transfection of a
negative control (similar results were observed by Western
blotting [data not shown]).
We used the online RNAhybrid program to predict stable
miRNA:mRNA interactions between miR-US5-2 and the US7
FIG. 1. US7 is cotargeted by miR-US5-1 and miR-US5-2. (A) Diagram depicting the genomic positions of miR-US5-1 and miR-US5-2. The
black arrows indicate the position and direction of the miRNAs. The second miR-US5-2 binding site is labeled as miR-US5-2 site #2. Open reading
frames near viral miRNAs are shown in light gray block arrows. (B) The 3UTR of US7 or a negative control 3UTR were cloned downstream
of the Rluc gene within a dual reporter construct. The constructs were then transfected into HEK293T cells with the indicated HCMV-encoded
miRNAs or a negative control miRNA (NEG). Eighteen hours posttransfection, luciferase assays were performed to determine the level of Rluc
activity normalized to Fluc activity. (C) Forty-eight hours posttransfection, Western blot analyses were performed using an antibody specific for
Fluc (luciferase) or GAPDH as a loading control.
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3UTR (28). Six interactions with a minimum free energy
(mfe) of 20 kcal/mole were predicted including the com-
pletely complementary site (42.4 kcal/mole). The second
most stable interaction (28.0 kcal/mol) used extensive G-U
base pairing, which does not support stable miRNA:mRNA
interactions (8). We therefore chose to mutate the bases that
gave the third most stable interaction (25.5 kcal/mol) con-
sisting of a 6-base pair seed sequence match (termed a 7-mer
seed sequence) in the US7 3UTR, shown in Fig. 4B and C.
Similar to the previous observation after mutation of the first
site, we observed a partial restoration of expression (42%)
upon mutation of this site (Fig. 4A, Mut 2). We therefore
mutated both sites simultaneously and observed that luciferase
activity was restored to 100%, demonstrating that miR-US5-2
interacts with the US7 3UTR at two independent sites (Fig.
4A, Mut 1&2).
To evaluate the contribution of all miR-US5-1 and miR-
US5-2 sites together, all three target sites were mutated simul-
taneously and tested. We found that mutation of all three sites
resulted in the complete restoration of expression of the re-
porter compared to the negative control in the presence of
both miRNAs (Fig. 4D). This demonstrates that miR-US5-1
and miR-US5-2 coregulate US7 through three functional sites
within the 3UTR. miR-US5-1 regulates US7 through one
functional site, while miR-US5-2 regulates US7 through two
functional sites.
miR-US5-2 downregulates US7 using two distinct mecha-
nisms. Surprisingly, we noted that each miR-US5-2 target site
within the US7 3UTR contributed equally to repression me-
diated by miR-US5-2 (50% by each) despite the fact that one
site is fully complementary to the miRNA while the other has
only a 7-mer seed sequence match. This effect was seen either
when miR-US5-2 was tested by itself or upon coregulation with
miR-US5-1. In mammalian cells, miRNAs with complete com-
plementarity to the target mRNA behave like an siRNA and
induce rapid mRNA degradation through endonucleolytic
cleavage. Incomplete base pairing between miRNA:mRNA
hybrids, however, results in translational repression through a
variety of mechanisms that do not necessarily involve RNA
degradation or decay (reviewed in reference 9). To determine
the mechanism(s) of miR-US5-1 and miR-US5-2 inhibition,
we measured US7 mRNA levels after cotransfection with miR-
US5-1 or miR-US5-2. As shown in Fig. 5A, US7 mRNA was
reduced in the presence of miR-US5-1 and miR-US5-2, sug-
gesting that both miRNAs repress US7 at the RNA level. In a
separate experiment, we used the Rluc construct containing
the US7 3UTR to determine the contribution of each miR-
US5-2 binding site to the stability of the mRNA. We observed
a decrease in Rluc transcript abundance when a construct
containing the wild-type 3UTR was used (Fig. 5B). However,
when the site with complete complementarity to miR-US5-2
was mutated, the Rluc transcript was stabilized. Mutation of
both sites also resulted in stabilization of the transcript. In
contrast, mutation of the imperfectly matched site failed to
stabilize the transcript. This demonstrates that interaction be-
tween miR-US5-2 and its fully complementary target site in-
duces transcript degradation, similar to what is seen with miR-
US5-1. In contrast, interaction through the imperfectly
matched site has no effect on transcript stability.
Taken together, these results suggest that miR-US5-2 mod-
ulates expression of US7 by two distinct but equally efficient
mechanisms.
miR-US5-1 and miR-US5-2 downregulate US7 expression at
later times in infection. To determine whether miR-US5-1 and
miR-US5-2 regulate endogenous US7 expression after infec-
FIG. 2. miR-US5-1 and miR-US5-2 act synergistically to down-
regulate US7. (A) Luciferase assays were performed on cells cotrans-
fected with the US7 WT 3UTR luciferase reporter construct and
various combinations of miR-US5-1 and miR-US5-2 as indicated in
Materials and Methods. Dose pairs of miRNAs yielding 50% inhibi-
tion of luciferase activity were determined from titration curves and
plotted onto a Cartesian graph. The line connecting the plots corre-
sponding to miR-US5-1 and miR-US5-2 alone is the line of additivity.
Dots located below the line of additivity indicate synergy. (B) Analysis
of cells transfected with the US7 WT 3UTR luciferase reporter con-
struct and dilutions of miR-US5-2.
FIG. 3. miR-US5-1 interacts with the US7 3UTR at one functional
site. Site-directed mutagenesis was used to mutate the predicted miR-
US5-1 target site in the US7 3UTR luciferase reporter construct.
Reporter constructs encoding the wild-type US7 3UTR or the mu-
tated US7 3UTR (US5-1 Mutant) were cotransfected into cells with
either a negative control miRNA (NEG) or the indicated miR(s). Dual
luciferase analyses were performed to examine reporter activity 16 h
posttransfection.
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tion of cells with HCMV, we constructed viral mutants lacking
the 70 nucleotides coding for the miR-US5-1 or miR-US5-2
pre-miRNAs. In addition, we constructed a virus deleted for
193 nucleotides encoding both miR-US5-1 and miR-US5-2
(unpublished data). All 3 viruses demonstrated a small but
reproducible growth defect in primary fibroblasts, which was
mainly attributable to a defect in the release of virus. The same
growth defect was observed after independent construction of
3 viruses lacking miR-US5-2, suggesting that the growth defect
was not due to a second site mutation (data not shown). We
infected cells with each of the mutant viruses or wild-type virus,
metabolically labeled the cells, and performed immunoprecipi-
tations using antibodies specific for US7. We normalized US7
expression to the expression of glycoprotein H (gH) as a con-
trol. As shown in Fig. 6, we observed an increase in the ex-
pression of endogenous US7 in the absence of the miRNAs as
compared to wild-type virus. Densitometry revealed a 2- to
3-fold increase in US7 expression in the absence of miR-US5-1
or miR-US5-2 and an almost 4-fold increase in the absence of
both. A second experiment using the miR-US5-2-deleted virus
showed that the US7 overabundance was not observed until
after 48 h of infection, a time at which miRNAs begin to be
expressed (12).
DISCUSSION
In this study we identify a new target of HCMV-encoded
miRNAs, the viral US7 gene. We show that the regulation of
US7 is complex, involving two miRNAs, miR-US5-1 and miR-
US5-2. miR-US5-1 regulates US7 by binding to a completely
complementary site within the US7 3UTR, resulting in strong
repression of a reporter construct containing this 3UTR. miR-
US5-2 binds to both a completely complementary site and an
additional site composed of 6 nucleotides within the seed se-
quence. Surprisingly, site-directed mutagenesis of each site
demonstrated that both were comparable in directing the re-
pression of a reporter construct. This is especially noteworthy
given that binding of miR-US5-2 to the completely comple-
mentary site resulted in a decrease in transcript abundance,
while binding of miR-US5-2 to the imperfectly matched site
did not. This suggests that translational repression due to in-
complete miRNA:mRNA pairing can exert an effect equal to
that of repression resulting from complete pairing. To our
knowledge, this is the first demonstration of a gene that is
regulated through both mechanisms.
miRNAs have a robust effect on gene expression, yet anal-
ysis of the effect of a single miRNA on its target often shows
FIG. 4. miR-US5-2 interacts with the US7 3UTR at two independent sites. (A) Site-directed mutagenesis was used to mutate the perfectly
matched miR-US5-2 binding site (US7 Mut 1), the 6-mer miR-US5-2 binding site (US7 Mut 2), or both binding sites (US7 Mut1&2) in the US7
3UTR luciferase reporter construct. Reporter constructs containing a negative control 3UTR (NEG) or the WT or mutated US7 3UTRs were
cotransfected into cells with miR-US5-2. (B) The US7 3UTR sequence. The genomic location of the sequence in AD169 is indicated (196372 to
195383). The perfectly matched miR-US5-2 binding site is highlighted in gray, the perfectly matched miR-US5-1 binding site is underlined, and
the 6-mer miR-US5-2 binding site is underlined and in boldface. (C) RNAhybrid was used to predict alternate miR-US5-2:US7 3UTR interaction
sites. The predicted structure of the second miR-US5-2:US7 mRNA interaction containing the 6-mer seed sequence match is shown. The top
strand is the miR-US5-2 sequence, while the bottom strand is the US7 3UTR sequence. (D) Site-directed mutagenesis was used to mutate the
single miR-US5-1 and the two miR-US5-2 binding sites simultaneously. Cells were cotransfected with either the reporter construct encoding
wild-type US7 3UTR or a 3UTR in which all three sites were mutated (Triple Mutant) along with a negative control miRNA (NEG) or the
indicated miR(s). Dual luciferase reporter assays were performed 16 h posttransfection.
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only modest changes in expression. Global bioinformatic anal-
ysis of miRNAs and predicted target genes have suggested that
tandem binding sites for one miRNA and binding sites for
multiple miRNAs may affect the strength of repression (16, 20,
35). A few experimental studies have supported this (11, 17, 20,
24, 37, 38). However, detailed analyses into the rules governing
coregulation by miRNAs are lacking. We used HCMV-en-
coded miRNAs, miR-US5-1 and miR-US5-2, to examine the
coregulation of a viral gene, US7.
We used an isobologram analysis to show that miR-US5-1
and miR-US5-2 have a highly synergistic effect on the US7
3UTR. This effect is seen even at very low concentrations of
miRNAs. The effect is functional in the context of a viral
infection, as viruses lacking miR-US5-1 or miR-US5-2 express
higher levels of US7, while a virus lacking both expresses even
greater amounts of US7. Previous reports have identified spac-
ing constraints between miRNA binding sites that affect coop-
erativity between miRNAs (15, 16, 30). Sites spaced between
16 and 35 nucleotides apart (measured from the beginning of
each binding site) resulted in cooperativity between the
miRNAs, while shorter or longer distances inhibited cooperativity.
In the US7 3UTR, there is a perfectly matched miR-US5-2
site followed by a perfectly matched miR-US5-1 site followed
by a second imperfectly matched miR-US5-2 site. There are
128 bases between the first two sites and 79 bases between the
second two sites. None of these spacings predict cooperativity,
suggesting that longer spacings between miRNAs can also re-
sult in synergistic effects. One important difference with pre-
vious studies on miRNA cooperativity is that the US7 3UTR
contains a mix of perfectly and imperfectly matched target sites
that regulate US7 expression through at least two distinct
mechanisms. It is possible that synergy between miRNAs tar-
geting imperfectly matched sites occurs only when they are
closely spaced due to the more efficient recruitment of shared
cofactors, similar to what has been described for response
elements and transcription factors (7, 19). In contrast, when
different mechanisms are at play like in the US7 situation, the
synergy between miRNAs might result from a different set of
interactions that do not require closely spaced sites. It will be
interesting to determine whether miR-US5-1 acts coopera-
tively with miR-US5-2 through either or both of the miR-
US5-2 binding sites.
Although the primary RNA that encodes miR-US5-1 and
miR-US5-2 has not yet been identified, it is likely they are
derived from the same transcript due to their close proximity,
FIG. 5. miR-US5-2 downregulates US7 using two distinct mecha-
nisms. (A) Plasmid containing the US7 open reading frame and pre-
dicted 3UTR or empty plasmid was transfected into cells with either
negative control miRNA or the indicated miR(s). Twenty-four hours
after transfection, RNA was isolated and RT-PCR analysis was per-
formed using primer probe sets specific for US7 and GAPDH (for
CT normalization). Relative amounts of US7 mRNA are shown.
(B) Reporter constructs containing the wild-type US7 3UTR or
3UTRs with the perfectly matched miR-US5-2 site (Mut 1), the im-
perfectly matched 6-mer miR-US5-2 site (Mut 2), or both (Mut 1 	 2)
were mutated were transfected into cells. Twenty-four hours after
transfection, RNA was isolated and RT-PCR analysis was performed
using primer probe sets specific to Rluc and Fluc. Rluc expression was
normalized to Fluc by CT, and relative Rluc mRNA is shown.
FIG. 6. miR-US5-1 and miR-US5-2 downregulate US7 during in-
fection. (A) Primary human fibroblasts were infected with either wild-
type, miR-US5-1 (US5-1 KO), miR-US5-2 (US5-2 KO), or miR-US5-1
plus US5-2 (US5-1	5-2 KO) mutant viruses. Ninety-six hours postin-
fection, the cells were metabolically labeled with [35S]methionine-cys-
teine for 60 min prior to the performance of immunoprecipitations
using antibodies specific for US7 or glycoprotein H (gH). The intensity
of the bands for each protein at each time point was quantitated using
ImageQuant. US7 expression was normalized to gH expression. (B and
C) Primary human fibroblasts were infected with either AD169 wild-
type virus or miR-US5-2 (US5-2 KO) mutant viruses. At the indicated
hours postinfection, cells were metabolically labeled with [35S]methio-
nine-cysteine for 60 min prior to the performance of immunoprecipi-
tations using antibodies specific for US7 or glycoprotein H (gH).
(B) Representative gel. M, mock infection. Numbers at top represent
hours postinfection. (C) The intensity of the bands for each protein at
each time point was quantitated using ImageQuant. US7 expression
was normalized to gH, and the fold increase in US7 expression relative
to gH is shown over time.
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thus ensuring coexpression and tight regulation of US7. Bioin-
formatics has suggested that mammalian genes targeted by
multiple miRNAs are involved in cellular processes that cause
disease when regulation is perturbed (e.g., cell cycle progres-
sion genes) (16). The US7 protein is an endoplasmic reticulum
(ER)-retained protein of unknown function. A positional ho-
molog for HCMV US7 exists in the rhesus CMV (RhCMV)
genome (Rh186). We have determined that Rh186 is also
strongly regulated by RhCMV-encoded miRNAs (unpublished
data), highlighting the importance of the regulation of these
genes. Studies are under way to determine the role of US7
during viral infection.
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